AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 169 filers reported holding AXSOME THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 0.60 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $24,970,939 | +344.6% | 310,198 | +286.0% | 1.30% | +266.7% |
| Q3 2023 | $5,616,920 | -56.4% | 80,368 | -55.2% | 0.35% | -58.1% |
| Q2 2023 | $12,880,330 | +72.7% | 179,242 | +48.3% | 0.84% | +76.9% |
| Q1 2023 | $7,456,865 | +97.4% | 120,896 | +20.9% | 0.48% | +115.8% |
| Q4 2021 | $3,778,000 | -47.2% | 100,000 | +15.0% | 0.22% | -51.0% |
| Q2 2020 | $7,156,000 | +66.3% | 86,978 | +18.9% | 0.45% | +13.3% |
| Q1 2020 | $4,304,000 | – | 73,163 | – | 0.40% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 788,263 | $35,172,000 | 44.43% |
| Fairmount Funds Management LLC | 1,896,647 | $84,628,000 | 14.88% |
| ACT CAPITAL MANAGEMENT, LLC | 73,000 | $3,257,000 | 4.50% |
| Ghost Tree Capital, LLC | 300,000 | $13,386,000 | 3.76% |
| Ikarian Capital, LLC | 407,600 | $18,188,000 | 3.62% |
| Paradigm Biocapital Advisors LP | 520,080 | $23,206,000 | 3.09% |
| MORGAN JESS S & CO INC | 78,895 | $3,520,000 | 3.06% |
| PFM Health Sciences, LP | 1,659,733 | $74,057,000 | 2.68% |
| RTW INVESTMENTS, LP | 1,882,164 | $83,982,000 | 1.94% |
| Ghost Tree Capital, LLC | 150,000 | $6,693,000 | 1.88% |